CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Rising demand for monoclonal antibodies
4.1.2. Increasing R&D expenditure in biopharmaceuticals
4.2. Market Restraints & Challenges
4.2.1. Lack of skilled professionals and highly qualified researchers
4.3. Market Opportunities
4.3.1. Patient Expiry
4.3.2. Increasing number of CMOs (Contract Manufacturing Organizations) and CROs
(Contract Research Organizations)
CHAPTER 5. GLOBAL HYDROPHOBIC INTERACTION CHROMATOGRAPHY
MARKET – BY PRODUCT & SERVICE
5.1. Products
5.1.1. Resins
5.1.1.1. Bead-Based Resins
5.1.1.2. Membrane-Based Resins
5.1.2. Columns
5.1.2.1. Empty Columns
5.1.2.2. Prepacked Columns
5.1.3. HIC Columns, By Material
5.1.3.1. Stainless Steel Columns
5.1.3.2. Glass & Plastic Columns
5.1.4. Buffers
5.1.5. Others
5.3. Services
CHAPTER 6. GLOBAL HYDROPHOBIC INTERACTION CHROMATOGRAPHY
MARKET – BY SAMPLE TYPE
6.1. Monoclonal Antibodies
6.2. Vaccines
6.3. Others
CHAPTER 7. GLOBAL HYDROPHOBIC INTERACTION CHROMATOGRAPHY
MARKET – BY APPLICATION
7.1. Pharmaceuticals
7.2. Drug Discovery
7.3. Genetic Engineering
7.4. Diagnostics
7.5. Food and Beverages
7.6. Water and Environment Analysis
7.7. Others
CHAPTER 8. GLOBAL HYDROPHOBIC INTERACTION CHROMATOGRAPHY
MARKET – BY END USER
8.1. Academic Institutes & Research Centers
8.2. Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs)
8.3. Pharmaceutical & Biotechnology Companies
CHAPTER 9. GLOBAL HYDROPHOBIC INTERACTION CHROMATOGRAPHY
MARKET - BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10. GLOBAL HYDROPHOBIC INTERACTION CHROMATOGRAPHY
MARKET - COMPANY PROFILES
10.1. JNC Corporation
10.2. Bio-Rad Laboratories, Inc.
10.3. Waters Corporation
10.4. Tosoh Corporation
10.5. Mitsubishi Chemical Corporation
10.6. Danaher Corporation
10.7. Thermo Fisher Scientific
10.8. Geno Technology
10.9. GE Healthcare
10.10. Merck KGaA
10.11. Sepax Technologies
10.12. Pacific Biosciences, Inc.
10.13. Avantor Performance Materials
10.14. Knauer
10.15. Repligen Corporation
CHAPTER 11. GLOBAL HYDROPHOBIC INTERACTION CHROMATOGRAPHY
MARKET - COMPETITIVE LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12. MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13. APPENDIX
13.1. List of Tables
13.2. List of Figures
